Patients with non-ischaemic dilated cardiomyopathy and hyper-responders to cardiac resynchronization therapy: characteristics and long-term evolution
- PMID: 19240110
- DOI: 10.1093/europace/eup035
Patients with non-ischaemic dilated cardiomyopathy and hyper-responders to cardiac resynchronization therapy: characteristics and long-term evolution
Abstract
Aims: In some patients with non-ischaemic dilated cardiomyopathy (NIDCM), left bundle branch block (LBBB), and severe cardiac failure, cardiac resynchronization therapy (CRT) has been shown to reverse almost completely left ventricular (LV) function. These patients thus eligible to be qualified 'hyper-responders' are exclusively recruited in patients with NIDCM. Evaluate proportion of 'hyper-responders' among patients with NIDCM and try to determine their profile before implantation of CRT.
Methods and results: Consecutive patients with DCM [LV ejection fraction (LVEF) <35%, LV end-diastolic diameter >60 mm], sinus rhythm, LBBB, and New York Heart Association (NYHA) class III and IV implanted with a CRT were prospectively followed. Patients were considered 'hyper-responders' if they fulfilled after a minimum period of 6 months the following criteria: functional recovery (NYHA class I or II) and LVEF >or=50%. Among the 51 NIDCM patients, 11 (21.5%) were 'hyper-responders' following CRT (LVEF increased from 26 +/- 9 to 59 +/- 6%, P < 0.01). In the 40 (78.5%) remaining patients, there was no or minimal functional improvement and only a modest increase in LVEF from 21 +/- 9 to 26 +/- 12% (P = 0.03). Comparison between 'hyper-responders' and remaining patients showed that baseline parameters of 'hyper-responders' were less severely deteriorated.
Conclusion: In a significant subset of patients with CRT for NIDCM, a 'complete' functional recovery associated with normalization of LV function was observed. This observation suggests that LBBB could be the causative factor of DCM in this subgroup of patients. There was not a unique discriminating factor at baseline between 'hyper-responders' and remaining patients.
Similar articles
-
Comparison of benefits from cardiac resynchronization therapy in patients with ischemic cardiomyopathy versus idiopathic dilated cardiomyopathy.Am J Cardiol. 2004 Apr 1;93(7):860-3. doi: 10.1016/j.amjcard.2003.12.024. Am J Cardiol. 2004. PMID: 15050489
-
Evaluation of left bundle branch block as a reversible cause of non-ischaemic dilated cardiomyopathy with severe heart failure. A new concept of left ventricular dyssynchrony-induced cardiomyopathy.Europace. 2005 Nov;7(6):604-10. doi: 10.1016/j.eupc.2005.06.005. Epub 2005 Sep 13. Europace. 2005. PMID: 16216764
-
Identification of 'super-responders' to cardiac resynchronization therapy: the importance of symptom duration and left ventricular geometry.Europace. 2009 Mar;11(3):343-9. doi: 10.1093/europace/eup038. Europace. 2009. PMID: 19240109 Clinical Trial.
-
[How the natural history of dilated cardiomyopathy has changed. Review of the Registry of Myocardial Diseases of Trieste].Ital Heart J Suppl. 2004 Apr;5(4):253-66. Ital Heart J Suppl. 2004. PMID: 15185463 Review. Italian.
-
Cardiac resynchronization therapy in heart failure patients: an update.Cardiol J. 2009;16(3):197-209. Cardiol J. 2009. PMID: 19437393 Review.
Cited by
-
Left Bundle Branch Block-associated Cardiomyopathy: A New Approach.Arrhythm Electrophysiol Rev. 2024 Sep 25;13:e15. doi: 10.15420/aer.2024.14. eCollection 2024. Arrhythm Electrophysiol Rev. 2024. PMID: 39450115 Free PMC article. Review.
-
Regression of fragmented QRS complex: a marker of electrical reverse remodeling in cardiac resynchronization therapy.Ann Noninvasive Electrocardiol. 2015 Jan;20(1):18-27. doi: 10.1111/anec.12172. Epub 2014 Jul 7. Ann Noninvasive Electrocardiol. 2015. PMID: 25040593 Free PMC article.
-
Measures of endothelial dysfunction predict response to cardiac resynchronisation therapy.Open Heart. 2016 Jun 7;3(1):e000391. doi: 10.1136/openhrt-2015-000391. eCollection 2016. Open Heart. 2016. PMID: 27335654 Free PMC article.
-
Roles and indications for use of implantable defibrillator and resynchronization therapy in the prevention of sudden cardiac death in heart failure.Heart Fail Rev. 2016 Jul;21(4):433-46. doi: 10.1007/s10741-016-9542-y. Heart Fail Rev. 2016. PMID: 26910804 Review.
-
Hyper-response to cardiac resynchronization with permanent His bundle pacing: Is parahisian pacing sufficient?HeartRhythm Case Rep. 2015 Nov;1(6):429-433. doi: 10.1016/j.hrcr.2015.05.006. Epub 2015 Sep 3. HeartRhythm Case Rep. 2015. PMID: 27722091 Free PMC article. No abstract available.
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Research Materials